Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 1Critical Illness 1Acute Kidney Injury 1

Interventions

daratumumab 2Urination 2Plasma Exchange 2sodium sulfate 1glucarpidase 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Stents 1Spironolactone 1Renal Replacement Therapy 1Renal Dialysis 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Ischemic Preconditioning 1Hypothermia, Induced 1Hyperthermic Intraperitoneal Chemotherapy 1Hemodiafiltration 1Drug Therapy 1Cisplatin 1Cilastatin 1Antibiotic Prophylaxis 1Anesthetics 1Aminophylline 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acute Kidney Injury × Spironolactone × Genitourinary × Clear all
NCT02531412 2017-01-04

SPIROCAN

Instituto Nacional de Cancerologia de Mexico

Phase 2/3 Unknown
24 enrolled
Genitourinary

Neoplasms, Critical Illness, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡